Tech Company Financing Transactions
Psylink Funding Round
On 7/29/2025, Psylink secured $570 thousand in Seed investment from Coinvest Capital, BSV Ventures and Firstpick.
Transaction Overview
Company Name
Announced On
7/29/2025
Transaction Type
Venture Equity
Amount
$570,000
Round
Seed
Investors
Proceeds Purpose
The capital will be used to advance Psylink's proprietary biotechnology platform for the sustainable production of plant- and fungi-derived compounds.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Zemale Street 29-3
Kaunas, Undisclosed
Lithuania
Kaunas, Undisclosed
Lithuania
Phone
Undisclosed
Website
Email Address
Overview
Psylink is a biotechnology company offering a novel solution to psychedelic drug development
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Laura Korsakova
Browse more venture capital transactions:
Prev: 7/29/2025: FluidCloud venture capital transaction
Next: 7/29/2025: Kinvard Bio venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. VC transactions reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs